Tyrphostin AG 112
CAS No. 144978-82-5
Tyrphostin AG 112( —— )
Catalog No. M22092 CAS No. 144978-82-5
Tyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 174 | In Stock |
|
| 100MG | 258 | In Stock |
|
| 500MG | 626 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTyrphostin AG 112
-
NoteResearch use only, not for human use.
-
Brief DescriptionTyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
-
DescriptionTyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number144978-82-5
-
Formula Weight236.23
-
Molecular FormulaC13H8N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (529.15 mM)
-
SMILESNC(=C(/C#N)C#N)\C(C#N)=C\c1ccc(O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rodrigo Franco, et al. Epidermal Growth Factor Receptor Is Activated by Hyposmolarity and Is an Early Signal Modulating Osmolyte Efflux Pathways in Swiss 3T3 Fibroblasts. Pflugers Arch. 2004 Mar;447(6):830-9.
molnova catalog
related products
-
BI-4020
BI-4020 is a fourth-generation, non-covalent, and orally active inhibitor of EGFR tyrosine kinase.
-
WHI-P258
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
-
Lazertinib
Lazertinib (YH25448, GNS-1480) is a highly potent, mutant-selective, irreversible, brain-penetrant and orally active EGFR tyrosine-kinase inhibitors for both the T790M mutation and activating EGFR mutations.
Cart
sales@molnova.com